Sartorius Aktiengesellschaft SUVPF Stock
Sartorius Aktiengesellschaft Price Chart
Sartorius Aktiengesellschaft SUVPF Financial and Trading Overview
| Sartorius Aktiengesellschaft stock price | 270.29 USD |
| Previous Close | 270.29 USD |
| Open | 256.25 USD |
| Bid | 274.57 USD x 100 |
| Ask | 293.39 USD x 100 |
| Day's Range | 256.25 - 256.25 USD |
| 52 Week Range | 221.24 - 312.93 USD |
| Volume | 1 USD |
| Avg. Volume | 28 USD |
| Market Cap | 18.66B USD |
| Beta (5Y Monthly) | 1.458 |
| PE Ratio (TTM) | 81.90576 |
| EPS (TTM) | 3.3 USD |
| Forward Dividend & Yield | 0.85 (0.30%) |
| Ex-Dividend Date | March 27, 2026 |
| 1y Target Est | N/A |
SUVPF Valuation Measures
| Enterprise Value | 23.6B USD |
| Trailing P/E | 81.90576 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 1.04 |
| Price/Sales (ttm) | 5.2109537 |
| Price/Book (mrq) | 5.900482 |
| Enterprise Value/Revenue | 6.589 |
| Enterprise Value/EBITDA | 25.146 |
Trading Information
Sartorius Aktiengesellschaft Stock Price History
| Beta (5Y Monthly) | 1.458 |
| 52-Week Change | 18.02% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 312.93 USD |
| 52 Week Low | 221.24 USD |
| 50-Day Moving Average | 256.25 USD |
| 200-Day Moving Average | 268.43 USD |
SUVPF Share Statistics
| Avg. Volume (3 month) | 28 USD |
| Avg. Daily Volume (10-Days) | 23 USD |
| Shares Outstanding | 34.81M |
| Float | 27.45M |
| Short Ratio | N/A |
| % Held by Insiders | 25.61% |
| % Held by Institutions | 30.78% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.74 |
| Trailing Annual Dividend Yield | 0.27% |
| 5 Year Average Dividend Yield | 33.00% |
| Payout Ratio | 0.2615 |
| Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 5.47% |
| Operating Margin (ttm) | 17.99% |
| Gross Margin | 45.71% |
| EBITDA Margin | 26.20% |
Management Effectiveness
| Return on Assets (ttm) | 3.92% |
| Return on Equity (ttm) | 7.17% |
Income Statement
| Revenue (ttm) | 3.58B USD |
| Revenue Per Share (ttm) | 51.24 USD |
| Quarterly Revenue Growth (yoy) | 3.10% |
| Gross Profit (ttm) | 1.64B USD |
| EBITDA | 938.5M USD |
| Net Income Avi to Common (ttm) | 196.1M USD |
| Diluted EPS (ttm) | 3.3 |
| Quarterly Earnings Growth (yoy) | 102.79% |
Balance Sheet
| Total Cash (mrq) | 291.3M USD |
| Total Cash Per Share (mrq) | 4.22 USD |
| Total Debt (mrq) | 4.05B USD |
| Total Debt/Equity (mrq) | 101.37 USD |
| Current Ratio (mrq) | 1.138 |
| Book Value Per Share (mrq) | 45.807953 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 912M USD |
| Levered Free Cash Flow (ttm) | 324.69M USD |
Profile of Sartorius Aktiengesellschaft
| Country | United States |
| State | N/A |
| City | Göttingen |
| Address | Otto-Brenner-Strasse 20 |
| ZIP | 37079 |
| Phone | 49 551 308 0 |
| Website | https://www.sartorius.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 14279 |
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Q&A For Sartorius Aktiengesellschaft Stock
What is a current SUVPF stock price?
Sartorius Aktiengesellschaft SUVPF stock price today per share is 270.29 USD.
How to purchase Sartorius Aktiengesellschaft stock?
You can buy SUVPF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sartorius Aktiengesellschaft?
The stock symbol or ticker of Sartorius Aktiengesellschaft is SUVPF.
Which industry does the Sartorius Aktiengesellschaft company belong to?
The Sartorius Aktiengesellschaft industry is Medical Instruments & Supplies.
How many shares does Sartorius Aktiengesellschaft have in circulation?
The max supply of Sartorius Aktiengesellschaft shares is 69.05M.
What is Sartorius Aktiengesellschaft Price to Earnings Ratio (PE Ratio)?
Sartorius Aktiengesellschaft PE Ratio is 81.90576000 now.
What was Sartorius Aktiengesellschaft earnings per share over the trailing 12 months (TTM)?
Sartorius Aktiengesellschaft EPS is 3.3 USD over the trailing 12 months.
Which sector does the Sartorius Aktiengesellschaft company belong to?
The Sartorius Aktiengesellschaft sector is Healthcare.
